Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Fred P. Lampropoulos sold 40,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $36.86, for a total value of $1,474,400.00. Following the sale, the chief executive officer now directly owns 1,079,991 shares of the company’s stock, valued at $39,808,468.26. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of MMSI opened at $36.18 on Friday. The stock has a market capitalization of $2.01 billion, a P/E ratio of 21.41, a P/E/G ratio of 1.72 and a beta of 1.03. Merit Medical Systems, Inc. has a twelve month low of $36.17 and a twelve month high of $66.34. The company has a 50 day moving average of $49.08 and a 200-day moving average of $55.55. The company has a quick ratio of 1.27, a current ratio of 2.42 and a debt-to-equity ratio of 0.48.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.08). The business had revenue of $255.50 million for the quarter, compared to the consensus estimate of $258.58 million. Merit Medical Systems had a return on equity of 10.40% and a net margin of 4.10%. Merit Medical Systems’s revenue was up 13.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.43 earnings per share. On average, sell-side analysts anticipate that Merit Medical Systems, Inc. will post 1.79 earnings per share for the current fiscal year.

A number of analysts recently issued reports on the company. Zacks Investment Research raised Merit Medical Systems from a “sell” rating to a “hold” rating and set a $63.00 target price for the company in a research note on Monday, July 1st. Wells Fargo & Co cut Merit Medical Systems from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $71.00 to $46.00 in a research note on Friday, July 26th. Barrington Research reissued a “buy” rating and set a $59.00 target price on shares of Merit Medical Systems in a research note on Friday, July 26th. Needham & Company LLC cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Friday, July 26th. Finally, Piper Jaffray Companies set a $58.00 target price on Merit Medical Systems and gave the stock an “overweight” rating in a research note on Friday, July 26th. Two analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $61.75.

Several institutional investors and hedge funds have recently modified their holdings of the company. State of Alaska Department of Revenue grew its stake in shares of Merit Medical Systems by 0.9% during the 1st quarter. State of Alaska Department of Revenue now owns 18,502 shares of the medical instruments supplier’s stock worth $1,143,000 after acquiring an additional 165 shares in the last quarter. FDx Advisors Inc. boosted its holdings in shares of Merit Medical Systems by 3.3% in the 2nd quarter. FDx Advisors Inc. now owns 6,318 shares of the medical instruments supplier’s stock valued at $376,000 after buying an additional 200 shares during the last quarter. Arizona State Retirement System boosted its holdings in shares of Merit Medical Systems by 0.3% in the 1st quarter. Arizona State Retirement System now owns 84,695 shares of the medical instruments supplier’s stock valued at $5,237,000 after buying an additional 251 shares during the last quarter. First Mercantile Trust Co. boosted its holdings in shares of Merit Medical Systems by 6.1% in the 1st quarter. First Mercantile Trust Co. now owns 4,699 shares of the medical instruments supplier’s stock valued at $290,000 after buying an additional 270 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan boosted its holdings in shares of Merit Medical Systems by 1.7% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 16,420 shares of the medical instruments supplier’s stock valued at $978,000 after buying an additional 280 shares during the last quarter. 98.83% of the stock is owned by institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Featured Article: How much can an individual set aside as a catch-up contribution?

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.